☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Lymph Node
Merck's Keytruda (pembrolizumab) Receives FDA's Approval for Adjuvant Treatment of Patients with Melanoma with Involvement of Lymp...
February 20, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.